Snap-8
Acetyl octapeptide-3 · SNAP-8 · Acetyl octapeptide-8
Snap-8 (Acetyl Octapeptide-3) is the aggressive, next-generation evolutionary upgrade to Argireline. By elongating the peptide chain by two critical amino acids, researchers drastically magnified its binding affinity and structural stability. It is deployed in ultra-high-end dermal formulations to enact significantly deeper and more enduring anti-wrinkle efficacy, particularly targeting deeply entrenched furrow lines that are resistant to standard hexapeptides.
Use-case scores
0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.
- Skin / cosmetic3.5/10
Longer SNARE-targeting analog. Cosmetic file, not a drug.
Compound card
- Class
- Acetyl octapeptide-3 (topical cosmetic; Argireline analog class)
- Formula
- C41H70N16O16S
- Status
- Not FDA-approved · research use
How it works
SNAP-8 (Acetyl Octapeptide-3) is a synthetic cosmetic peptide representing an elongated version of Argireline (which is a hexapeptide). It works via the exact same mechanism: mimicking the SNAP-25 protein to competitively block the formation of the SNARE complex, thereby inhibiting the release of acetylcholine at the neuromuscular junction in the skin.
Because it is an octapeptide (8 amino acids long), it reportedly binds to the SNARE complex more effectively than Argireline, providing approximately 30% greater wrinkle-reducing efficacy in manufacturer clinical trials.
Source: Lipotec technical bulletin, 2010
Background & History
SNAP-8 (acetyl octapeptide-3) was developed by Lipotec as a successor to the highly successful Argireline (acetyl hexapeptide-3). By extending the peptide chain from 6 to 8 amino acids, the goal was to achieve greater binding affinity at the SNARE complex and thus more potent wrinkle reduction at lower concentrations. It is widely used in premium Korean and Western anti-aging formulations.
Research Use Cases
- ✓Expression wrinkle reduction
- ✓Forehead line softening
- ✓Crow's feet treatment
- ✓Premium anti-aging serums
Dosing
| Phase | Dose | Frequency | Notes |
|---|---|---|---|
| Cosmetic Use | 5% - 10% solution | Topical, 1-2x daily | Often formulated alongside Matrixyl or Argireline in premium anti-aging serums. |
Administration
Timeline
Who it is for
Cosmetic Anti-Aging
LowAdvanced topical neurotransmitter-inhibiting peptide for dynamic wrinkles.
Safety & Considerations
Topical cosmetic. Not a neuromuscular drug. Does not cause systemic neuromuscular blockade.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Limits of current evidence
- INCI cosmetic evidence, not an NDA.
Verdict
SNAP-8 is a topical octapeptide in the Argireline family. Not Botox. Not injectable “baby Botox.”
Interactions & Contraindications
Topical only. Compatible with most cosmetic actives. May be less effective if used simultaneously with products containing high concentrations of exfoliating acids that disrupt the stratum corneum.
Synergies & Common Stacks
SNAP-8 and Argireline target the same SNARE complex but at different binding sites. Often combined in formulations for maximum neuromuscular relaxation.
SNARE-complex cosmetic peptide plus matrikine cosmetic peptide. Dual-claim serums are not an anti-aging NDA.
Frequently Asked Questions
What is the difference between SNAP-8 and Argireline?▼
References
- Blanes-Mira C, et al. “Acetyl hexapeptide-3 in a cosmetic formulation acts on skin mechanical properties.” Int J Cosmet Sci (2002). PMID: 18498517
Looking for a trusted source? See our recommended suppliers
Independently tested · COA-verified · Save 10% with our exclusive code